This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1545968309347685v1 1545968309347685v2    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Lima, C. Articles by Peduzzi, J. D. PubMed PubMed Citation Articles by Lima, C. Articles by Peduzzi, J. D. Social Bookmarking                         What's this?

Olfactory Mucosal Autografts and Rehabilitation for Chronic Traumatic Spinal Cord Injury

^* To whom correspondence should be addressed. E-mail: carlosvlima{at}sapo.pt.

	Abstract

Background/objective. Basic science advances in spinal cord injury (SCI) are leading to novel clinical approaches.The authors report a prospective, uncontrolled pilot study of the safety and outcomes of implanting olfactory mucosal autografts (OMA) in 20 patients with chronic,sensorimotor complete or motor complete SCI. Methods.Seven paraplegic and 13 tetraplegic subjects (17 men and 3 women; 19-37 years old) who sustained a traumatic SCI 18 to 189 months previously (mean = 49 months) were enrolled. Preoperative rehabilitation that emphasized lower extremity stepping using either overground walking training or a robotic weight-supported treadmill training was provided for 25 to 39 hours per week for a median of 4 months at 3 sites. No change in ASIA Impairment Scale (AIS) motor scores for the lower extremities or AIS grades of completeness was found. OMAs were transplanted into 1.3-to 4-cm lesions at C4-T12 neurological levels after partial scar removal.Therapy was continued postoperatively.Preoperative and postoperative assessments includedAIS scores and classification, electromyography (EMG) of attempted voluntary contractions, somatosensory evoked potentials (SSEP),urodynamic studies with sphincter EMG, spinal cord magnetic resonance imaging (MRI), and otolaryngology and psychology evaluations.The Functional Independence Measure (FIM) and Walking Index for Spinal Cord Injury (WISCI) were obtained in 13 patients. Results. All patients survived and recovered olfaction.One patient was rehospitalized for aseptic meningitis.Minor adverse events occurred in 4 others.The mean duration of follow-up was 27.7 months (range = 12-45 months). By MRI, the lesion site was filled in all patients with no neoplastic overgrowth or syringomyelia.AIS grades improved in 11 of 20 patients, 6 (A C),3 (B C),and 2 (A B), and declined in 1 (B A). Improvements included new voluntary EMG responses (15 patients) and SSEPs (4 patients). Scores improved in the FIM and WISCI (13/13 tested), and urodynamic responses improved in 5 patients. Conclusion. OMA is feasible, relatively safe, and possibly beneficial in people with chronic SCI when combined with postoperative rehabilitation. Future controlled trials may need to include a lengthy and intensive rehabilitation arm as a control.

First published on September 30, 2009, doi:10.1177/1545968309347685
This version was published on October 19, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?